Optimization of tumor-treating field therapy for triple-negative breast cancer cells in vitro via frequency modulation

PURPOSE: Currently, tumor-treating field (TTField) therapy utilizes a single “optimal” frequency of electric fields to achieve maximal cell death in a targeted population of cells. However, because of differences in cell size, shape, and ploidy during mitosis, optimal electric field characteristics...

Descripción completa

Detalles Bibliográficos
Autores principales: Smothers, Austin R., Henderson, Jason R., O’Connell, John J., Stenbeck, Jonathan M., Dean, Delphine, Booth, Brian W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245511/
https://www.ncbi.nlm.nih.gov/pubmed/37287008
http://dx.doi.org/10.1186/s12935-023-02959-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245511/
https://www.ncbi.nlm.nih.gov/pubmed/37287008
http://dx.doi.org/10.1186/s12935-023-02959-x

Ejemplares similares